Example: Heart Attack

Search clinical trials for: Artesunate

Total 186 results

NCT04921930

Not yet recruiting

Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)

Conditions: Friedreich Ataxia
NCT00297882

Completed

Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon

Conditions: Malaria
NCT04475107

Completed

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Conditions: COVID-19
NCT03792516

Recruiting

Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

Conditions: Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease, Vulva Intraepithelial Neoplasia, Vulvar Diseases
NCT04618523

Recruiting

Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo

Conditions: Malaria
NCT02084602

Completed

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

Conditions: Malaria, Falciparum
NCT04706130

Recruiting

Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure

Conditions: Vivax Malaria
NCT02354534

Completed

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

Conditions: Cervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain)
NCT03100045

Active, not recruiting

Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

Conditions: HPV-Related Anal Intraepithelial Neoplasia, AIN2/3, Artesunate, Alternative Treatment, Anal Dysplasia, Precancerous Conditions, Human Papilloma Virus
NCT04829695

Not yet recruiting

Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon

Conditions: Falciparum Malaria
NCT04701606

Recruiting

The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients

Conditions: Covid19
NCT03923725

Recruiting

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.

Conditions: Plasmodium Falciparum Malaria (Uncomplicated)
NCT04098744

Recruiting

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Conditions: CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
NCT04387240

Not yet recruiting

Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19

Conditions: Covid 19 Positive, Corona Virus Infection
NCT04675931

Not yet recruiting

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

Conditions: Severe Malaria
NCT03640403

Active, not recruiting

Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania

Conditions: Malaria,Falciparum, Anemia
NCT03726593

Recruiting

Drug Combinations of Atovaquone-Proguanil (AP) With ACT

Conditions: Plasmodium Falciparum Malaria (Drug Resistant)
NCT02653898

Active, not recruiting

Malaria Elimination Pilot Study in Military Forces in Cambodia

Conditions: Malaria, Parasitic Diseases
NCT02297477

Active, not recruiting

The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia

Conditions: Malaria
NCT03893097

Active, not recruiting

Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children

Conditions: Schistosoma Haematobium, Schistosoma Mansoni
NCT04695197

Recruiting

Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso

Conditions: Covid-19, Malaria
NCT04713631

Not yet recruiting

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

Conditions: Crohn's Disease
NCT04532931

Recruiting

COVID-19 Treatment in South Africa

Conditions: COVID-19
NCT04374019

Recruiting

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

Conditions: COVID, Sars-CoV2
NCT01707199

Completed

SPK Study in Afghanistan

Conditions: Uncomplicated P. Falciparum Malaria